Green Thumb Industries Inc. (GTBIF)
(Delayed Data from OTC)
$6.75 USD
+0.84 (14.21%)
Updated Aug 1, 2025 03:59 PM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
GTBIF 6.75 +0.84(14.21%)
Will GTBIF be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GTBIF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GTBIF
Cannabis Operator CRLBF Plans California Exit: How to Play the Stock?
Cannabis Operator Green Thumb Down 30% YTD: Time to Buy, Sell or Hold?
GTBIF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Green Thumb Industries Inc. (GTBIF) Q1 Earnings and Revenues Miss Estimates
Green Thumb Industries Inc. (GTBIF) Lags Q4 Earnings Estimates
AtriCure (ATRC) Reports Q4 Loss, Lags Revenue Estimates
Other News for GTBIF
Trump privately backed marijuana rescheduling since taking office: Scotts Miracle-Gro CEO
U.S. Senate confirms President Trump’s DEA pick
Cannabis Stock Movers For July 15, 2025
House appropriations bill blocks marijuana rescheduling
Marijuana rescheduling process remains stalled, DEA says